NCT06949072View on ClinicalTrials.gov

A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

September 11, 2025

Study Completion Date

September 11, 2025

Conditions
Dental Caries
Interventions
DRUG

Test Dentifrice

Dentifrice containing 5 percent (%) weight by weight (w/w) Potassium nitrate (KNO3) and 1150ppm fluoride as sodium fluoride.

DRUG

Reference Dentifrice

Dentifrice containing 1100ppm fluoride as stannous fluoride.

DRUG

Negative Control Dentifrice

Dentifrice containing 5% KNO3 with no fluoride.

Trial Locations (1)

46202

Oral Health Research Institute, Indianapolis

All Listed Sponsors
lead

HALEON

INDUSTRY